Net Income (Loss) Attributable to Parent in USD of ANAVEX LIFE SCIENCES CORP. from Q2 2010 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Anavex Life Sciences Corp. quarterly/annual Net Income (Loss) Attributable to Parent history and change rate from Q2 2010 to Q3 2025.
  • Anavex Life Sciences Corp. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was -$9.83M, a 15.4% increase year-over-year.
  • Anavex Life Sciences Corp. Net Income (Loss) Attributable to Parent for the twelve months ending 30 Sep 2025 was -$46.4M, a 7.85% decline year-over-year.
  • Anavex Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2025 was -$46.4M, a 7.85% decline from 2024.
  • Anavex Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2024 was -$43M, a 9.48% increase from 2023.
  • Anavex Life Sciences Corp. annual Net Income (Loss) Attributable to Parent for 2023 was -$47.5M, a 0.99% increase from 2022.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

ANAVEX LIFE SCIENCES CORP. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 -$46.4M -$9.83M +$1.79M +15.4% 01 Jul 2025 30 Sep 2025 10-K 25 Nov 2025
Q2 2025 -$48.2M -$13.2M -$1.03M -8.43% 01 Apr 2025 30 Jun 2025 10-Q 12 Aug 2025
Q1 2025 -$47.1M -$11.2M -$650K -6.16% 01 Jan 2025 31 Mar 2025 10-Q 13 May 2025
Q4 2024 -$46.5M -$12.1M -$3.49M -40.5% 01 Oct 2024 31 Dec 2024 10-Q 12 Feb 2025
Q3 2024 -$43M -$11.6M -$1.47M -14.5% 01 Jul 2024 30 Sep 2024 10-K 25 Nov 2025
Q2 2024 -$41.5M -$12.2M -$934K -8.28% 01 Apr 2024 30 Jun 2024 10-Q 12 Aug 2025
Q1 2024 -$40.6M -$10.5M +$2.56M +19.5% 01 Jan 2024 31 Mar 2024 10-Q 13 May 2025
Q4 2023 -$43.2M -$8.62M +$4.35M +33.5% 01 Oct 2023 31 Dec 2023 10-Q 12 Feb 2025
Q3 2023 -$47.5M -$10.1M +$4.14M +29% 01 Jul 2023 30 Sep 2023 10-K 25 Nov 2025
Q2 2023 -$51.6M -$11.3M +$1.09M +8.79% 01 Apr 2023 30 Jun 2023 10-Q 06 Aug 2024
Q1 2023 -$52.7M -$13.1M -$2.67M -25.6% 01 Jan 2023 31 Mar 2023 10-Q 09 May 2024
Q4 2022 -$50.1M -$13M -$2.09M -19.2% 01 Oct 2022 31 Dec 2022 10-Q 07 Feb 2024
Q3 2022 -$48M -$14.3M -$2.57M -21.9% 01 Jul 2022 30 Sep 2022 10-K 27 Nov 2023
Q2 2022 -$45.4M -$12.4M -$2.19M -21.5% 01 Apr 2022 30 Jun 2022 10-Q 08 Aug 2023
Q1 2022 -$43.2M -$10.4M -$2.28M -28% 01 Jan 2022 31 Mar 2022 10-Q 09 May 2023
Q4 2021 -$40.9M -$10.9M -$3.03M -38.5% 01 Oct 2021 31 Dec 2021 10-Q 07 Feb 2023
Q3 2021 -$37.9M -$11.7M -$5.75M -96.4% 01 Jul 2021 30 Sep 2021 10-K 27 Nov 2023
Q2 2021 -$32.2M -$10.2M -$3.69M -56.9% 01 Apr 2021 30 Jun 2021 10-Q 12 Aug 2021
Q1 2021 -$28.5M -$8.16M -$919K -12.7% 01 Jan 2021 31 Mar 2021 10-Q 13 May 2021
Q4 2020 -$27.5M -$7.86M -$1.26M -19.2% 01 Oct 2020 31 Dec 2020 10-Q 09 Feb 2022
Q3 2020 -$26.3M -$5.97M -$359K -6.4% 01 Jul 2020 30 Sep 2020 10-K 28 Nov 2022
Q2 2020 -$25.9M -$6.49M +$35.3K +0.54% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 -$26M -$7.24M +$10.2K +0.14% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 -$26M -$6.59M +$328K +4.74% 01 Oct 2019 31 Dec 2019 10-Q 16 Feb 2021
Q3 2019 -$26.3M -$5.61M -$14K -0.25% 01 Jul 2019 30 Sep 2019 10-K 28 Dec 2020
Q2 2019 -$26.3M -$6.52M -$3.67M -129% 01 Apr 2019 30 Jun 2019 10-Q 06 Aug 2020
Q1 2019 -$22.6M -$7.25M -$2.49M -52.5% 01 Jan 2019 31 Mar 2019 10-Q 07 May 2020
Q4 2018 -$20.1M -$6.92M -$2.86M -70.5% 01 Oct 2018 31 Dec 2018 10-Q 06 Feb 2020
Q3 2018 -$17.3M -$5.59M -$438K -8.49% 01 Jul 2018 30 Sep 2018 10-K 16 Dec 2019
Q2 2018 -$16.8M -$2.85M +$761K +21.1% 01 Apr 2018 30 Jun 2018 10-Q 07 Aug 2019
Q1 2018 -$17.6M -$4.75M -$3.2M -207% 01 Jan 2018 31 Mar 2018 10-Q 09 May 2019
Q4 2017 -$14.4M -$4.06M -$913K -29% 01 Oct 2017 31 Dec 2017 10-Q 07 Feb 2019
Q3 2017 -$13.5M -$5.15M +$1.36M +20.8% 01 Jul 2017 30 Sep 2017 10-K 25 Jan 2019
Q2 2017 -$14.8M -$3.61M -$1.37M -61.1% 01 Apr 2017 30 Jun 2017 10-Q 09 Aug 2018
Q1 2017 -$13.4M -$1.55M +$482K +23.7% 01 Jan 2017 31 Mar 2017 10-Q 10 May 2018
Q4 2016 -$13.9M -$3.15M +$808K +20.4% 01 Oct 2016 31 Dec 2016 10-Q 07 Feb 2018
Q3 2016 -$14.7M -$6.51M -$1.15M -21.6% 01 Jul 2016 30 Sep 2016 10-K 25 Jan 2019
Q2 2016 -$13.6M -$2.24M +$2M +47.2% 01 Apr 2016 30 Jun 2016 10-Q 07 Aug 2017
Q1 2016 -$15.6M -$2.03M -$306K -17.7% 01 Jan 2016 31 Mar 2016 10-Q 10 May 2017
Q4 2015 -$15.3M -$3.95M -$3.17M -403% 01 Oct 2015 31 Dec 2015 10-Q 07 Feb 2017
Q3 2015 -$12.1M -$5.36M +$2.94M +35.5% 01 Jul 2015 30 Sep 2015 10-K 11 Dec 2017
Q2 2015 -$15.1M -$4.24M -$3.23M -320% 01 Apr 2015 30 Jun 2015 10-Q 11 Aug 2016
Q1 2015 -$11.8M -$1.72M -$706K -69.3% 01 Jan 2015 31 Mar 2015 10-Q 11 May 2016
Q4 2014 -$11.1M -$787K -$1.15M -319% 01 Oct 2014 31 Dec 2014 10-Q 08 Feb 2016
Q3 2014 -$9.97M -$8.3M -$5.31M -178% 01 Jul 2014 30 Sep 2014 10-K 14 Dec 2016
Q2 2014 -$4.66M -$1.01M -$857K -564% 01 Apr 2014 30 Jun 2014 10-Q 14 Aug 2015
Q1 2014 -$3.8M -$1.02M -$913K -860% 01 Jan 2014 31 Mar 2014 10-Q 14 May 2015
Q4 2013 -$2.89M $359K +$812K 01 Oct 2013 31 Dec 2013 10-Q 17 Feb 2015
Q3 2013 -$3.7M -$2.99M -$2.31M -343% 01 Jul 2013 30 Sep 2013 10-K 29 Dec 2014
Q2 2013 -$1.39M -$152K +$4.39M +96.7% 01 Apr 2013 30 Jun 2013 10-Q 13 Aug 2014
Q1 2013 -$5.78M -$106K +$804K +88.3% 01 Jan 2013 31 Mar 2013 10-Q/A 30 May 2014
Q4 2012 -$6.58M -$454K +$1.72M +79.1% 01 Oct 2012 31 Dec 2012 10-Q 14 Feb 2014
Q3 2012 -$8.3M -$674K +$1.19M +63.9% 01 Jul 2012 30 Sep 2012 10-Q/A 30 May 2014
Q2 2012 -$9.5M -$4.54M -$2.96M -188% 01 Apr 2012 30 Jun 2012 10-Q 14 Aug 2013
Q1 2012 -$6.53M -$910K +$1.06M +53.9% 01 Jan 2012 31 Mar 2012 10-Q 17 May 2013
Q4 2011 -$7.6M -$2.17M -$288K -15.3% 01 Oct 2011 31 Dec 2011 10-Q 14 Feb 2013
Q3 2011 -$7.31M -$1.87M 01 Jul 2011 30 Sep 2011 10-Q/A 30 May 2014
Q2 2011 -$1.58M +$387K +19.7% 01 Apr 2011 30 Jun 2011 10-Q 17 Aug 2012
Q1 2011 -$1.97M 01 Jan 2011 31 Mar 2011 10-Q 15 May 2012
Q4 2010 -$1.89M 01 Oct 2010 31 Dec 2010 10-Q 14 Feb 2012
Q2 2010 -$1.97M 01 Apr 2010 30 Jun 2010 10-Q 12 Aug 2011

ANAVEX LIFE SCIENCES CORP. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2025 -$46.4M -$3.38M -7.85% 01 Oct 2024 30 Sep 2025 10-K 25 Nov 2025
2024 -$43M +$4.5M +9.48% 01 Oct 2023 30 Sep 2024 10-K 25 Nov 2025
2023 -$47.5M +$473K +0.99% 01 Oct 2022 30 Sep 2023 10-K 25 Nov 2025
2022 -$48M -$10.1M -26.6% 01 Oct 2021 30 Sep 2022 10-K 27 Nov 2023
2021 -$37.9M -$11.6M -44.2% 01 Oct 2020 30 Sep 2021 10-K 27 Nov 2023
2020 -$26.3M +$14.5K +0.06% 01 Oct 2019 30 Sep 2020 10-K 28 Nov 2022
2019 -$26.3M -$9.04M -52.4% 01 Oct 2018 30 Sep 2019 10-K 28 Dec 2020
2018 -$17.3M -$3.79M -28.2% 01 Oct 2017 30 Sep 2018 10-K 16 Dec 2019
2017 -$13.5M +$1.28M +8.66% 01 Oct 2016 30 Sep 2017 10-K 25 Jan 2019
2016 -$14.7M -$2.63M -21.7% 01 Oct 2015 30 Sep 2016 10-K 25 Jan 2019
2015 -$12.1M -$2.14M -21.5% 01 Oct 2014 30 Sep 2015 10-K 11 Dec 2017
2014 -$9.97M -$6.27M -169% 01 Oct 2013 30 Sep 2014 10-K 14 Dec 2016
2013 -$3.7M +$4.6M +55.4% 01 Oct 2012 30 Sep 2013 10-K 29 Dec 2014
2012 -$8.3M -$995K -13.6% 01 Oct 2011 30 Sep 2012 10-Q/A 30 May 2014
2011 -$7.31M +$1.48M +16.8% 01 Oct 2010 30 Sep 2011 10-Q/A 30 May 2014
2010 -$8.78M 01 Oct 2009 30 Sep 2010 10-Q/A 30 May 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.